1. Home
  2. NWTG vs CDIO Comparison

NWTG vs CDIO Comparison

Compare NWTG & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

HOLD

Current Price

$1.28

Market Cap

4.8M

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$2.07

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWTG
CDIO
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
5.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
NWTG
CDIO
Price
$1.28
$2.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.4K
29.7K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
99.09
N/A
EPS
N/A
N/A
Revenue
$8,135,000.00
$14,825.00
Revenue This Year
$53.21
$171,906.75
Revenue Next Year
$40.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
136.14
N/A
52 Week Low
$0.70
$0.97
52 Week High
$2.07
$7.91

Technical Indicators

Market Signals
Indicator
NWTG
CDIO
Relative Strength Index (RSI) 63.99 61.91
Support Level $0.99 $1.68
Resistance Level $1.39 $2.16
Average True Range (ATR) 0.08 0.17
MACD 0.02 0.06
Stochastic Oscillator 80.00 68.33

Price Performance

Historical Comparison
NWTG
CDIO

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: